Home » Generic Industry Wary of New Packaging for Opioids; Contend it Could Delay Entry
Generic Industry Wary of New Packaging for Opioids; Contend it Could Delay Entry
The generic drug industry wants the FDA to ensure new requirements for packaging and technologies aimed at curbing opioid abuse don’t result in barriers to market entry for generic makers.
Generic Line
Drugs Commercial Operations Regulatory AffairsGeneric Line
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct